F20 F25
Conditions
Interventions
Group 1: Arm 1- Treatment as usual (TAU) involves the standard treatment of patients with non-affective psychosis at a psychiatric outpatient clinic (control group/TAU group). TAU includes regular psy
Sponsors
Evangelisches Klinikum Bethel (EvKB), Klinik für Psychiatrie und Psychotherapie
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: diagnosis of schizophrenia (ICD-10: F20) or schizoaffective disorder (ICD-10: F25); age between 18 and 65 years, willingness to undergo random allocation to 20 sessions of outpatient psychotherapy (CBT) or psychiatric outpatient TAU; written informed consent; sufficient knowledge of written and spoken German
Exclusion criteria
Exclusion criteria: current diagnosis of substance dependence; organic brain disease, serious and acute somatic illness, serious eating disorder (BMI < 15); acute suicidality at baseline, outpatient psychotherapy within the last two years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Positive and Negative Syndrome Scale assessed by the Structured Clinical Interview for the Positive and Negative Syndrome Scale (SCI-PANSS, Kay, Opler, & Fiszbein, 1992) is the primary outcome measure to quantify changes in schizophrenia symptoms at post-treatment (6 month after baseline) and at follow-up (12 month after baseline). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes include the cost-effectiveness of the CBT-treatment and the number of re-hospitalisations (efficiency of CBT). | — |
Countries
Germany
Contacts
Public ContactSilvia Carvalho Fernando
Evangelisches Klinikum Bethel (EvKB), Klinik für Psychiatrie und Psychotherapie
Outcome results
None listed